Staging Biomarkers in Preclinical Autosomal Dominant Alzheimer Disease by Estimated Years to Symptom Onset

INTRODUCTION: Staging preclinical Alzheimer disease (AD) by the expected years to symptom onset (EYO) in autosomal dominant AD (ADAD) through biomarker correlations is important. METHODS: We estimated the correlation matrix between EYO/cognition and imaging/CSF biomarkers, and searched for the EYO c...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Alzheimers Dement
Autores principales: Wang, Guoqiao, Coble, Dean, McDade, Eric M., Hassenstab, Jason, Fagan, Anne M., Benzinger, Tammie L.S., Bateman, Randall J., Morris, John C., Xiong, Chengjie
Formato: Artigo
Lenguaje:Inglês
Publicado: 2019
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6461496/
https://ncbi.nlm.nih.gov/pubmed/30773445
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jalz.2018.12.008
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares